• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二乙氧基-(1-苯基-1,3-丁二酮基)钛(IV)在人肿瘤异种移植中的临床前评估

Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.

作者信息

Mattern J, Keppler B, Volm M

出版信息

Arzneimittelforschung. 1984;34(10):1289-90.

PMID:6549134
Abstract

The antitumour activity of diethoxy-(1-phenyl-1,3-butanedionato)titanium (IV) (DBT) in comparison to cis-dichlorodiammine platinum (cisplatin, cis-DDP) and cyclophosphamide (CTX) against human breast, colo-rectal and lung tumour lines growing as xenografts in nude mice was investigated. The antitumour activities and toxicities of DBT and cis-DDP are comparable whereas CTX was the most effective agent.

摘要

研究了二乙氧基 -(1-苯基-1,3-丁二酮)钛(IV)(DBT)与顺式二氯二氨铂(顺铂,cis-DDP)和环磷酰胺(CTX)相比,对在裸鼠体内作为异种移植物生长的人乳腺癌、结肠直肠癌和肺癌细胞系的抗肿瘤活性。DBT和顺铂的抗肿瘤活性和毒性相当,而CTX是最有效的药物。

相似文献

1
Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.二乙氧基-(1-苯基-1,3-丁二酮基)钛(IV)在人肿瘤异种移植中的临床前评估
Arzneimittelforschung. 1984;34(10):1289-90.
2
Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.顺式二卤代双(1-苯基-1,3-丁二酮)钛(IV)化合物对Walker 256癌肉瘤的抗肿瘤活性。一类新型抗肿瘤药物。
Arzneimittelforschung. 1982;32(8):806-7.
3
Sensitivity of human non-small cell lung cancer xenografts to cyclophosphamide and cisplatin.人非小细胞肺癌异种移植瘤对环磷酰胺和顺铂的敏感性。
In Vivo. 1987 Jan-Feb;1(1):23-6.
4
Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium (IV) compounds. A new class of antineoplastic agents.顺式二卤代双(1-苯基-1,3-丁二酮)钛(IV)化合物的抗肿瘤活性。一类新型抗肿瘤药。
J Cancer Res Clin Oncol. 1983;105(1):109-10. doi: 10.1007/BF00391842.
5
Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.顺二氨二氯铂(II)对人肿瘤异种移植瘤的抗肿瘤活性取决于其在裸鼠体内的曲线下面积。
J Surg Oncol. 1996 Feb;61(2):138-42. doi: 10.1002/(SICI)1096-9098(199602)61:2<138::AID-JSO9>3.0.CO;2-D.
6
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.沙巴柔比星(MEN 10755)与顺铂(DDP)联合治疗对人肺肿瘤异种移植瘤的抗肿瘤作用
Cancer Chemother Pharmacol. 2008 Sep;62(4):621-9. doi: 10.1007/s00280-007-0645-y. Epub 2007 Nov 24.
7
Autochthonous, acetoxymethylmethylnitrosamine-induced colorectal cancer in rats: a useful tool in selecting new active antineoplastic compounds?大鼠原位乙氧羰甲基甲基亚硝胺诱导的结直肠癌:筛选新型活性抗肿瘤化合物的有用工具?
Hepatogastroenterology. 1986 Oct;33(5):227-34.
8
Tumor inhibition by titanocene complexes: activity against sarcoma 180.二茂钛配合物的肿瘤抑制作用:对肉瘤180的活性
Anticancer Res. 1986 Jan-Feb;6(1):33-7.
9
Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds.
Arzneimittelforschung. 1985;35(12):1832-6.
10
Effect of five antineoplastic agents on tumor xenografts with different growth rates.五种抗肿瘤药物对不同生长速率肿瘤异种移植瘤的影响。
J Natl Cancer Inst. 1984 Jun;72(6):1335-9.

引用本文的文献

1
Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections.不稳定金属配合物的有利反应性:基于金属的抗癌药物用于瘤内注射的潜在应用。
Pharmaceutics. 2022 Apr 4;14(4):790. doi: 10.3390/pharmaceutics14040790.
2
Antitumor activity of treosulfan in human lung carcinomas.苏消安在人肺癌中的抗肿瘤活性。
Cancer Chemother Pharmacol. 1996;37(3):211-21. doi: 10.1007/BF00688319.
3
Sequential methotrexate (MTX) and 5-fluorouracil (FU) in human tumor xenografts.
Med Oncol Tumor Pharmacother. 1985;2(1):27-32. doi: 10.1007/BF02934777.
4
Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.二茂钛配合物的肿瘤抑制作用:对两种异种移植的人肺癌的影响
J Cancer Res Clin Oncol. 1987;113(4):342-8. doi: 10.1007/BF00397717.
5
Antitumor activity of treosulfan against human breast carcinomas.
Cancer Chemother Pharmacol. 1992;31(2):103-10. doi: 10.1007/BF00685095.